2 great ASX blue chip shares growing globally
Jaz Harrison
March 27, 2021
There are a couple of great ASX blue chip shares
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
There are a couple of great ASX blue chip shares
The ASX 200 (INDEXASX:XJO) is tipped to start the day
The ASX 200 (INDEXASX:XJO) is set to open lower on
In my opinion, ASX growth shares might be the best
The ASX 200 (INDEXASX:XJO) is set to open lower on
Is there still good value to be found in the
BHP Group (ASX:BHP) are often considered as the backbone of
Vanguard Australian Shares Index ETF (ASX:VAS) is one of the
There are couple of very good reasons why the CSL
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.